Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins

Do you need to cut manufacturing costs?

The manufacturing costs of many recombinant proteins can be significantly reduced through increasing titres and improving the solubility of the proteins, reducing the necessities of costly downstream processes. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters, as well as for suppliers of industrial enzymes where the markets are smaller.

Vectron Biosolutions is your upstream expert on developing robust, cost-efficient production processes for recombinant proteins in E. coli and other bacteria. We have proprietary next-generation expression tools and decades of experience that is available to you through partnerships and licensing.

Latest news

  • Vectron signs license agreement with ArcticZymes

    December 20 | 2018

    Read more Download as PDF
  • Gold Medal

    October 24 | 2018

    The NTNU iGEM 2018 team won the Gold Medal in Boston.

    Read more
  • Vectron is featured in Dagens Næringsliv

    July 24 | 2018

    Vectron Biosolution was featured in Dagens Næringsliv on July 24, as one of the most interesting biotech startups in Norway.

  • VIVO career day at NTNU

    March 06 | 2018

    Vectron Biosolutions participated on this year's VIVO career day at NTNU

    Read more
Complete newslist


  • PepTalk: The Protein Science Week, San Diego, CA, USA

    Jan 14–18 | 2019
  • BIO-Europe Spring, Vienna, Austria

    Mar 25–27 | 2019
Meet us there!
More events